JP2002533359A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533359A5
JP2002533359A5 JP2000590483A JP2000590483A JP2002533359A5 JP 2002533359 A5 JP2002533359 A5 JP 2002533359A5 JP 2000590483 A JP2000590483 A JP 2000590483A JP 2000590483 A JP2000590483 A JP 2000590483A JP 2002533359 A5 JP2002533359 A5 JP 2002533359A5
Authority
JP
Japan
Prior art keywords
aav
composition
treating
minutes
infused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000590483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533359A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/031093 external-priority patent/WO2000038518A1/en
Publication of JP2002533359A publication Critical patent/JP2002533359A/ja
Publication of JP2002533359A5 publication Critical patent/JP2002533359A5/ja
Pending legal-status Critical Current

Links

JP2000590483A 1998-12-28 1999-12-28 組換えアデノ随伴ウイルスベクターを用いる、心筋細胞への効率的かつ安定なインビボでの遺伝子移入 Pending JP2002533359A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11392398P 1998-12-28 1998-12-28
US60/113,923 1998-12-28
PCT/US1999/031093 WO2000038518A1 (en) 1998-12-28 1999-12-28 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors

Publications (2)

Publication Number Publication Date
JP2002533359A JP2002533359A (ja) 2002-10-08
JP2002533359A5 true JP2002533359A5 (cg-RX-API-DMAC7.html) 2007-02-22

Family

ID=22352321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000590483A Pending JP2002533359A (ja) 1998-12-28 1999-12-28 組換えアデノ随伴ウイルスベクターを用いる、心筋細胞への効率的かつ安定なインビボでの遺伝子移入

Country Status (5)

Country Link
EP (1) EP1139751A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002533359A (cg-RX-API-DMAC7.html)
AU (1) AU763049B2 (cg-RX-API-DMAC7.html)
CA (1) CA2356551A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000038518A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745416B2 (en) * 1995-04-11 2010-06-29 The Regents Of The University Of California Method for in vivo regulation of cardiac muscle contractility
HK1048593A1 (zh) * 1999-11-05 2003-04-11 The Regents Of The University Of California 用於通过体内基因输送治疗心血管疾病的技术和组合物
EP1870473A1 (en) * 2000-08-17 2007-12-26 Keiya Ozawa Adeno-associated virus-mediated delivery of angiogenic factors
ES2288993T3 (es) * 2000-08-17 2008-02-01 Keiya Ozawa Distribucion de factores angiogenicos mediada por virus adenoasociados.
EP1324780A4 (en) * 2000-09-06 2005-06-22 Univ Johns Hopkins METHODS OF TREATING CARDIAC ARRHYTHMIA
US20030022870A1 (en) * 2001-06-01 2003-01-30 Victor Dzau Methods of treating cardiac disorders
AU2003299204A1 (en) 2002-10-02 2004-04-23 The Johns Hopkins University Focal calcium channel modulation
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
PL2044199T3 (pl) * 2006-07-25 2013-04-30 Celladon Corp Przedłużony, podawany z prądem krwi, nasierdziowy, wieńcowy wlew wektorów wirusowych na bazie wirusów towarzyszących adenowirusom, zawierający SERCA2a do terapii genowej
EP2244740A1 (en) 2008-02-19 2010-11-03 Celladon Corporation Compositions for enhanced uptake of viral vectors in the myocardium
CA2837322C (en) * 2011-05-26 2023-03-21 University Of Washington Cell and gene based methods to improve cardiac function
US12064470B2 (en) 2017-11-16 2024-08-20 Universite D'aix-Marseille FGF10 for the treatment of heart diseases
CA3099958A1 (en) 2018-04-16 2019-10-24 The Trustees Of The University Of Pennsylvania Compositions and methods for treating duchenne muscular dystrophy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792483A (en) * 1993-04-05 1998-08-11 Vickers, Inc. Injection molding machine with an electric drive
US6162796A (en) * 1995-09-27 2000-12-19 The Rockefeller University Method for transferring genes to the heart using AAV vectors

Similar Documents

Publication Publication Date Title
EP1620123B1 (en) Genetic modification of targeted regions of the cardiac conduction system
WO2002004623A3 (en) ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE
CA2516510A1 (en) Method of using adipose tissue-derived cells in the treatment of cardiovascular conditions
JP2006526012A (ja) 心臓導電系の標的化された領域の遺伝子修飾
US6685934B1 (en) Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)
JP2004506658A5 (cg-RX-API-DMAC7.html)
US20040175363A1 (en) Adenovirus comprising a gene coding for glutathione peroxidase
Won et al. Functional polymers of gene delivery for treatment of myocardial infarct
CA2368677A1 (en) Intramyocardial injection of autologous bone marrow
AU763049B2 (en) Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinantadeno-associated virus vectors
Bains et al. Gene therapy for cardiac arrhythmias
Giacca Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?
Greener et al. Gene therapy strategies for cardiac electrical dysfunction
Ebrahim et al. Genetic Modification of Mesenchymal Stem Cells for Neurological Disease Therapy: What Effects Does it Have on Phenotype/Cell Behavior, Determining Their Effectiveness? N. Ebrahim et al.
Imai Gene therapy approach in renal disease in the 21st century
WO2005062890A2 (en) Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel
Duckers et al. Prospects for genetic therapy of cardiovascular disease
CA2378740A1 (en) Gene therapy for enhancing and/or inducing angiogenesis
Remes et al. Gene transfer to the vascular system: Novel translational perspectives for vascular diseases
Veera et al. New approaches to cardiac gene therapy delivery
US20060128647A1 (en) Novel oligonucleotides and treating cardiac disorders by using the same
Keswani et al. Gene Transfer Techniques for Therapeutic Angiogenesis
Imai et al. Gene therapy for kidney disease
JP3095248B2 (ja) 核酸運搬体
Kelemen et al. Approaches for cardiovascular gene therapy in animal models